Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akira Inoue

Showing results (241-250 of 387) with videos related to

Pageof 39
Sort By:
Clinical Lung Cancer|February 15, 2024
Efficacy of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Metastatic Non-Small Cell Lung Cancer Patients with Poor Performance Status and Epidermal Growth Factor Receptor Mutations: Findings from the Japanese Lung Cancer Registry DatabaseYusuke Okuma, Yasushi Shintani, Ikuo Sekine, et al.
Lung Cancer (Amsterdam, Netherlands)|November 22, 2019
Phase II study of S-1 in patients with previously-treated invasive thymoma and thymic carcinoma: North Japan lung cancer study group trial 1203Yoko Tsukita, Akira Inoue, Shunichi Sugawara, et al.
The Oncologist|May 21, 2017
Phase II Study of Modified Carboplatin Plus Weekly Nab-Paclitaxel in Elderly Patients with Non-Small Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 1301Eisaku Miyauchi, Akira Inoue, Kazuhiro Usui, et al.
Journal of Molecular Biology|June 5, 2018
Structures of REV1 UBM2 Domain Complex with Ubiquitin and with a Small-Molecule that Inhibits the REV1 UBM2-Ubiquitin InteractionMurugendra Vanarotti, Christy R Grace, Darcie J Miller, et al.
International Journal of Clinical Oncology|November 13, 2020
Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naïve squamous cell carcinoma: North Japan lung cancer study group 1302Yosuke Kawashima, Toshiyuki Harada, Yuka Fujita, et al.
Respiratory Investigation|December 7, 2021
Expectations of respiratory physicians from psychologists in palliative care for patients with non-cancer respiratory diseasesYoshinobu Matsuda, Takako Kosugi, Masako Yamanaka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 6, 2022
[A Case of Signet-Ring Cell Carcinoma of the Ampulla of Vater in a Young Male]Yoshinori Yokono, Hisateru Komatsu, Tomoki Sugimoto, et al.
Human Cell|November 26, 2016
A mouse model reveals that Mfsd2a is critical for unfolded protein response upon exposure to tunicamycinHiroshi Moritake, Megumi Obara, Yusuke Saito, et al.
Cancer Science|February 28, 2020
A Japanese lung cancer registry study on demographics and treatment modalities in medically treated patientsIkuo Sekine, Yasushi Shintani, Takehito Shukuya, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 30, 2020
Factors influencing spiritual well-being in terminally ill cancer inpatients in JapanYusuke Hiratsuka, Sang-Yeon Suh, Isseki Maeda, et al.
Pageof 39

Showing results (241-250 of 387) with videos related to

Sort By:
Pageof 39
Clinical Lung Cancer|February 15, 2024
Efficacy of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Metastatic Non-Small Cell Lung Cancer Patients with Poor Performance Status and Epidermal Growth Factor Receptor Mutations: Findings from the Japanese Lung Cancer Registry DatabaseYusuke Okuma, Yasushi Shintani, Ikuo Sekine, et al.
Lung Cancer (Amsterdam, Netherlands)|November 22, 2019
Phase II study of S-1 in patients with previously-treated invasive thymoma and thymic carcinoma: North Japan lung cancer study group trial 1203Yoko Tsukita, Akira Inoue, Shunichi Sugawara, et al.
The Oncologist|May 21, 2017
Phase II Study of Modified Carboplatin Plus Weekly Nab-Paclitaxel in Elderly Patients with Non-Small Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 1301Eisaku Miyauchi, Akira Inoue, Kazuhiro Usui, et al.
Journal of Molecular Biology|June 5, 2018
Structures of REV1 UBM2 Domain Complex with Ubiquitin and with a Small-Molecule that Inhibits the REV1 UBM2-Ubiquitin InteractionMurugendra Vanarotti, Christy R Grace, Darcie J Miller, et al.
International Journal of Clinical Oncology|November 13, 2020
Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naïve squamous cell carcinoma: North Japan lung cancer study group 1302Yosuke Kawashima, Toshiyuki Harada, Yuka Fujita, et al.
Respiratory Investigation|December 7, 2021
Expectations of respiratory physicians from psychologists in palliative care for patients with non-cancer respiratory diseasesYoshinobu Matsuda, Takako Kosugi, Masako Yamanaka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 6, 2022
[A Case of Signet-Ring Cell Carcinoma of the Ampulla of Vater in a Young Male]Yoshinori Yokono, Hisateru Komatsu, Tomoki Sugimoto, et al.
Human Cell|November 26, 2016
A mouse model reveals that Mfsd2a is critical for unfolded protein response upon exposure to tunicamycinHiroshi Moritake, Megumi Obara, Yusuke Saito, et al.
Cancer Science|February 28, 2020
A Japanese lung cancer registry study on demographics and treatment modalities in medically treated patientsIkuo Sekine, Yasushi Shintani, Takehito Shukuya, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 30, 2020
Factors influencing spiritual well-being in terminally ill cancer inpatients in JapanYusuke Hiratsuka, Sang-Yeon Suh, Isseki Maeda, et al.
Pageof 39